Erbe Medical India Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 7.50 Cr
as on 16-11-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 52.94%
(FY 2023)
- Profit 123.53%
(FY 2023)
- Ebitda 142.21%
(FY 2023)
- Net Worth 51.55%
(FY 2023)
- Total Assets -7.37%
(FY 2023)
About Erbe Medical India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Christian Erbe, Marcus Felstead, Rakesh Kundu, and One other member serve as directors at the Company.
- CIN/LLPIN
U33119DL2007PTC429896
- Company No.
062336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2007
- Date of AGM
06 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Erbe Medical India Private Limited offer?
Erbe Medical India Private Limited offers a wide range of products and services, including Medical Equipment & Accessories, Medical Equipment, Surgical Accessories, Needle Electrodes, Dermatology Equipment, Cryosurgical System, Welding Electrodes, Tungsten Electrodes, Cautery Machine, Surgical Cautery Patient Plate.
Who are the key members and board of directors at Erbe Medical India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Kundu  | Managing Director | 09-Mar-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Christian Erbe  | Director | 09-Feb-2007 | Current |
| Marcus Felstead | Director | 07-Oct-2015 | Current |
| Daniel Zimmermann | Director | 20-Jan-2021 | Current |
Financial Performance of Erbe Medical India.
Erbe Medical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.94% increase. The company also saw a substantial improvement in profitability, with a 123.53% increase in profit. The company's net worth Soared by an impressive increase of 51.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erbe Medical India?
In 2023, Erbe Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Erbe Medical India?
Erbe Medical India has a workforce of 61 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erbe Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erbe Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
